Lyric Lab Inc, 175 E 112th St, Apt 2A, New York, NY 10029, US

Mount Sinai Lab in New York, NY is a renowned research institution specializing in genetics and genomics studies, with a particular focus on Inflammatory Bowel Disease (IBD), Parkinson's Disease, and cardiovascular disease. Their team of experts conducts groundbreaking research, such as the MECONIUM Study and the MELODY Trial, to advance our understanding of these complex conditions and develop innovative treatments. With a strong emphasis on genetics, the lab also investigates the genetics of the Ashkenazi Jewish population in relation to health and disease. As a leader in the field, Mount Sinai Lab publishes extensively on various topics, including obesity, diabetes, craniosynostosis, and the microbiome. Their team, led by Vice Chair Inga Peter, PhD, at the Icahn School of Medicine, is dedicated to pushing the boundaries of scientific knowledge and improving patient outcomes. With a commitment to excellence, Mount Sinai Lab is at the forefront of cutting-edge research in genetics and genomics.Generated from the website

Foxx Spot

Renaissance Technical Institute Inc